STAT July 23, 2024
Allison DeAngelis

When Sanjaya Singh left Johnson & Johnson in 2021, his former colleague Peter Lebowitz paid close attention.

Singh had been a mainstay in the immunology and oncology fields, helping to invent the blockbuster drug Skyrizi and several other treatments during stints at Johnson & Johnson and Boehringer Ingelheim. “If Sanjaya Singh is doing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article